RADIA: RNA and DNA integrated analysis for somatic mutation detection

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Radenbaugh, Amie J ^a   Ma, Singer ^a   Ewing, Adam ^a   Stuart, Joshua M ^a   Collisson, Eric A ^b   Zhu, Jingchun ^a   Haussler, David ^a,c  

^a University of California Santa Cruz   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; DNA; PROTEIN KINASE LKB1; PROTEIN P53; RNA;

ARTICLE; CDKN2A GENE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIUM CARCINOMA; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; HUMAN; HUMAN GENOME; LUNG ADENOCARCINOMA; PATIENT CODING; RNA AND DNA INTEGRATED ANALYSIS; SENSITIVITY AND SPECIFICITY; SOMATIC MUTATION; STK11 GENE; TP53 GENE; TUMOR GENE; ADENOCARCINOMA; COMPUTER PROGRAM; DNA SEQUENCE; ENDOMETRIUM TUMOR; GENETICS; LUNG TUMOR; MUTATION; PROCEDURES; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; ENDOMETRIAL NEOPLASMS; FEMALE; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; SOFTWARE;

EID: 84915819115     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111516     Document Type: Article

References (55)

1. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70.
2. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, et al. (1999) Creation of human tumour cells with defined genetic elements. Nature 400: 464-468.
3. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet 10: 57-63.
4. Gott JM, Emeson RB (2000) Functions and mechanisms of RNA editing. Annu Rev Genet 34: 499-531.
5. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, et al. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics 25: 2078-2079.
6. Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, et al. (2012) VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res 22: 568-576.
7. Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, et al. (2012) Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 28: 1811-1817.
8. Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, et al. (2012) SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28: 311-317.
9. Koboldt DC, Chen K, Wylie T, Larson DE, McLellan MD, et al. (2009) VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25: 2283-2285.
10. Goya R, Sun MG, Morin RD, Leung G, Ha G, et al. (2010) SNVMix: predicting single nucleotide variants from next-generation sequencing of tumors. Bioinformatics 26: 730-736.
11. Cibulskis K, Lawrence MS, Carter SL, Sivachenko A, Jaffe D, et al. (2013) Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat Biotechnol 31: 213-219.
12. Roberts ND, Kortschak RD, Parker WT, Schreiber AW, Branford S, et al. (2013) A comparative analysis of algorithms for somatic SNV detection in cancer. Bioinformatics 29: 2223-2230.
13. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, et al. (2013) Integrated genomic characterization of endometrial carcinoma. Nature 497: 67-73.
14. The Cancer Genome Atlas (2014) Comprehensive molecular profiling of lung adenocarcinoma. Nature 511: 543-550.
15. Li H (2011) Improving SNP discovery by base alignment quality. Bioinformatics 27: 1157-1158.
16. 1000 Genomes Project Consortium (2010) A map of human genome variation from population-scale sequencing. Nature 467: 1061-1073. (98)
17. 1000 Genomes Project Consortium (2012) An integrated map of genetic variation from 1, 092 human genomes. Nature 491: 56-65. (99)
18. Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, et al. (2001) dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 29: 308-311.
19. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, et al. (2002) The human genome browser at UCSC. Genome Res 12: 996-1006.
20. Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, et al. (2014) The UCSC Genome Browser database: 2014 update. Nucleic Acids Res 42: D764-770.
21. Musumeci L, Arthur JW, Cheung FS, Hoque A, Lippman S, et al. (2010) Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. Hum Mutat 31: 67-73.
22. Kalyana-Sundaram S, Kumar-Sinha C, Shankar S, Robinson DR, Wu YM, et al. (2012) Expressed pseudogenes in the transcriptional landscape of human cancers. Cell 149: 1622-1634.
23. Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, et al. (2012) GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res 22: 1760-1774.
24. Baertsch R, Diekhans M, Kent WJ, Haussler D, Brosius J (2008) Retrocopy contributions to the evolution of the human genome. BMC Genomics 9: 466.
25. Rosenbloom KR, Sloan CA, Malladi VS, Dreszer TR, Learned K, et al. (2013) ENCODE data in the UCSC Genome Browser: year 5 update. Nucleic Acids Res 41: D56-63.
26. Cingolani P, Platts A, Wang le L, Coon M, Nguyen T, et al. (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6: 80-92.
27. Kent WJ (2002) BLAT-the BLAST-like alignment tool. Genome Res 12: 656-664.
28. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
29. Wang K, Singh D, Zeng Z, Coleman SJ, Huang Y, et al. (2010) MapSplice: accurate mapping of RNA-seq reads for splice junction discovery. Nucleic Acids Res 38: e178.
30. Friedman PN, Chen X, Bargonetti J, Prives C (1993) The p53 protein is an unusually shaped tetramer that binds directly to DNA. Proc Natl Acad Sci U S A 90: 3319-3323.
31. Muller PA, Vousden KH (2012) p53 mutations in cancer. Nat Cell Biol 15: 2-8.
32. Kan Z, Jaiswal BS, Stinson J, Janakiraman V, Bhatt D, et al. (2010) Diverse somatic mutation patterns and pathway alterations in human cancers. Nature 466: 869-873.
33. Lindberg J, Mills IG, Klevebring D, Liu W, Neiman M, et al. (2013) The mitochondrial and autosomal mutation landscapes of prostate cancer. Eur Urol 63: 702-708.
34. Biankin AV, Waddell N, Kassahn KS, Gingras MC, Muthuswamy LB, et al. (2012) Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 491: 399-405.
35. Gui Y, Guo G, Huang Y, Hu X, Tang A, et al. (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43: 875-878.
36. Abaan OD, Polley EC, Davis SR, Zhu YJ, Bilke S, et al. (2013) The exomes of the NCI-60 panel: a genomic resource for cancer biology and systems pharmacology. Cancer Res 73: 4372-4382.
37. Pfaff E, Remke M, Sturm D, Benner A, Witt H, et al. (2010) TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastoma. J Clin Oncol 28: 5188-5196.
38. Alsner J, Yilmaz M, Guldberg P, Hansen LL, Overgaard J (2000) Heterogeneity in the clinical phenotype of TP53 mutations in breast cancer patients. Clin Cancer Res 6: 3923-3931.
39. Fernandez-Cuesta L, Oakman C, Falagan-Lotsch P, Smoth KS, Quinaux E, et al. (2012) Prognostic and predictive value of TP53 mutations in node-positive breast cancer patients treated with anthracycline-or anthracycline/taxane-based adjuvant therapy: results from the BIG 02-98 phase III trial. Breast Cancer Res 14: R70.
40. Gartel AL, Feliciano C, Tyner AL (2003) A new method for determining the status of p53 in tumor cell lines of different origin. Oncol Res 13: 405-408.
41. The Cancer Genome Atlas (2012) Comprehensive molecular portraits of human breast tumours. Nature 490: 61-70.
42. Jones S, Wang TL, Ie-Shih M, Mao TL, Nakayama K, et al. (2010) Frequent mutations of chromatin remodeling gene ARID1A in ovarian clear cell carcinoma. Science 330: 228-231.
43. Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, et al. (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488: 43-48.
44. Kim TH, Lee SY, Rho JH, Jeong NY, Soung YH, et al. (2009) Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells. Mol Cancer Res 7: 1645-1654.
45. Davies H, Hunter C, Smith R, Stephens P, Greenman C, et al. (2005) Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 65: 7591-7595.
46. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, et al. (2012) Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell 150: 1107-1120.
47. Andujar P, Wang J, Descatha A, Galateau-Salle F, Abd-Alsamad I, et al. (2010) p16INK4A inactivation mechanisms in non-small-cell lung cancer patients occupationally exposed to asbestos. Lung Cancer 67: 23-30.
48. Blons H, Pallier K, Le Corre D, Danel C, Tremblay-Gravel M, et al. (2008) Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma. BMC Med Genomics 1: 25.
49. The Cancer Genome Atlas (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature 487: 330-337.
50. Takahira T, Oda Y, Tamiya S, Yamamoto H, Kawaguchi K, et al. (2004) Alterations of the p16INK4a/p14ARF pathway in clear cell sarcoma. Cancer Sci 95: 651-655.
51. Nagy E, Beck Z, Kiss A, Csoma E, Telek B, et al. (2003) Frequent methylation of p16INK4A and p14ARF genes implicated in the evolution of chronic myeloid leukaemia from its chronic to accelerated phase. Eur J Cancer 39: 2298-2305.
52. Ueki T, Hsing AW, Gao YT, Wang BS, Shen MC, et al. (2004) Alterations of p16 and prognosis in biliary tract cancers from a population-based study in China. Clin Cancer Res 10: 1717-1725.
53. Ku CS, Wu M, Cooper DN, Naidoo N, Pawitan Y, et al. (2012) Exome versus transcriptome sequencing in identifying coding region variants. Expert Rev Mol Diagn 12: 241-251.
54. Cirulli ET, Singh A, Shianna KV, Ge D, Smith JP, et al. (2010) Screening the human exome: a comparison of whole genome and whole transcriptome sequencing. Genome Biol 11: R57.
55. Zhu J, Sanborn JZ, Benz S, Szeto C, Hsu F, et al. (2009) The UCSC Cancer Genomics Browser. Nat Methods 6: 239-240.